<--- Back to Details
First PageDocument Content
Kidney diseases / Kidney / Renal cell carcinoma / Urinary system / Von Hippel–Lindau tumor suppressor / Transitional cell carcinoma / Cancer / Ureteral cancer / Treatment and prognosis of renal cell carcinoma / Medicine / Oncology / Kidney cancer
Date: 2013-07-09 03:38:02
Kidney diseases
Kidney
Renal cell carcinoma
Urinary system
Von Hippel–Lindau tumor suppressor
Transitional cell carcinoma
Cancer
Ureteral cancer
Treatment and prognosis of renal cell carcinoma
Medicine
Oncology
Kidney cancer

Add to Reading List

Source URL: www.cancer.gov

Download Document from Source Website

File Size: 954,86 KB

Share Document on Facebook

Similar Documents

Medical physics / Physics / Radiation therapy / Radiobiology / Medicine / Radiation / Fast neutron therapy / Neutron / Calibration / Dosimetry / Collimator

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

DocID: 1xVse - View Document

Humancomputer interaction / User interface techniques / Human behavior / Software architecture / Computing / Computer / User interface / Graphical user interface

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

DocID: 1xViy - View Document

Health / Computing / Medical physics / Formal methods / Theoretical computer science / Therapy / Information and communications technology / Radiation therapy / Z notation / Computer / Software

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

DocID: 1xV2d - View Document

Computing / Models of computation / Software engineering / Control engineering / Cognition / State / Control theory / Lookup table / Variable / Dependent and independent variables

Formal Speci cation and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

DocID: 1xUvZ - View Document

Medicine / Clinical medicine / Cancer / Tyrosine kinase receptors / Breast cancer / Atezolizumab / ROS1 / Triple-negative breast cancer / Anaplastic lymphoma kinase / Trastuzumab emtansine / Entrectinib / Metastatic breast cancer

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

DocID: 1xTgE - View Document